CTSA K12 Program at Harvard Medical School

哈佛医学院 CTSA K12 项目

• 批准号: 10621595
• 负责人: Karen K Miller
• 金额: $ 161.98万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-15 至 2028-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10621595
• 关键词: Academic Medical Centers; Academy; Clinical; Clinical Investigator; Clinical Research; Clinical Sciences; Communities; Competence; Dedications; Development; Educational Curriculum; Elements; Ensure; Environment; Funding; Future; Goals; Growth; Health; Human; Infrastructure; Leadership; Medical Research; Mentored Clinical Scientist Development Program; Mentors; Mentorship; National Center for Advancing Translational Sciences; Performance; Program Development; Research; Research Personnel; Scholars Program; Science; Time; Training; Translating; Translational Research; United States National Institutes of Health; Work; career; career development; catalyst; community engagement; diversity and inclusion; educational atmosphere; improved; innovation; interdisciplinary collaboration; medical schools; programs; success; translational pipeline; translational scientist; visiting scholar

PROJECT SUMMARY The goal of the Harvard Catalyst K12 program is to create an environment for early-stage clinical and translational (CT) investigators that facilitates their career development and encourages paradigm-shifting, diversity-focused interdisciplinary collaboration and team-based research approaches to advance CT science. Since its founding in 2008, the Harvard Catalyst KL2 program has served as the cornerstone across Harvard Medical School (HMS) and its affiliated academic medical centers for training our most outstanding early-stage CT investigators. Given the demonstrated success of the KL2 program since 2008, the new K12 program will build on the KL2 program's strengths. The new K12 program will specifically seek to help train and develop the future leaders of CT science by leveraging the Harvard Catalyst cores and integrating the scholars into the broader CT infrastructure at Harvard Catalyst and the CTSA consortium. In addition, through dedicated funding from the HMS-affiliated AMCs, the K12 program will continue to be paired with the Catalyst Medical Research Investigator (CMeRIT) program to further enrich the K12 learning environment. Moreover, through the continued growth and expansion of the Clinical and Translational Research Academy, a supporting infrastructural element of Harvard Catalyst, the K12 will create a community for CT investigators and enhance the transition to independence for all K awardees across HMS. Finally, the K12 program will work closely with the Harvard Catalyst Cores and other NIH-funded programs at HMS to enhance the research capability, competency and performance of all K12 awardees with a new focus on translational science. The overarching objective of the program is to ensure and nurture the sustainable careers of early-stage CT investigators and ultimately advance translational science. The K12 program will offer sustained protected time for scholars to advance their CT research, overseen by a primary mentor and co-mentor and now further enhanced by a dedicated mentorship committee, including a separate career mentor to provide outside input on broader career goals. Training will include the use of new courses and programs, including our monthly Translate Together curriculum, that covers the broad translational spectrum and focuses on developing innovative solutions that improve human health. It will also include the development of individualized career development programs, leadership training, visibility through participation in the national CTSA Visiting Scholar Program, and mentor/mentee training, to ensure the success of each scholar as a translational scientist as envisioned by NCATS. The K12 will also seek to educate scholars on the importance of community engagement for the execution of effective CT research to ensure the highest quality science can be completed. In a related context, building on our earlier success in improving the diversity of the KL2 program, we will continue several diversity and inclusion initiatives both to ensure that we have a vibrant and diverse group of scholars but also to ensure that all scholars are fully educated on diversity as a critical feature of all successful CT research endeavors.

项目概要 哈佛 Catalyst K12 项目的目标是为早期临床和 转化（CT）研究者，促进他们的职业发展并鼓励范式转变， 以多样性为中心的跨学科合作和基于团队的研究方法来推进 CT 科学。 自 2008 年成立以来，Harvard Catalyst KL2 项目一直是哈佛的基石 医学院（HMS）及其附属学术医学中心，培养我们最优秀的早期阶段 CT 调查员。鉴于 KL2 计划自 2008 年以来取得的成功，新的 K12 计划将 发挥 KL2 计划的优势。新的 K12 计划将专门寻求帮助培训和发展 通过利用哈佛 Catalyst 核心并将学者融入到 CT 科学的未来领导者中 哈佛 Catalyst 和 CTSA 联盟更广泛的 CT 基础设施。此外，通过专项资金 来自 HMS 附属 AMC 的 K12 计划将继续与 Catalyst 医学研究配对 Investigator (CMeRIT) 计划进一步丰富了 K12 的学习环境。此外，通过持续 临床和转化研究学院的成长和扩张，这是一个支持性的基础设施 作为哈佛催化剂的一部分，K12 将为 CT 研究人员创建一个社区并加强过渡 为 HMS 的所有 K 获奖者争取独立。最后，K12项目将与哈佛紧密合作 HMS 的催化剂核心和其他 NIH 资助的项目，旨在提高研究能力、竞争力和 所有 K12 获奖者的表现，新的重点是转化科学。该组织的总体目标是 该计划旨在确保和培养早期 CT 研究人员的可持续职业生涯，并最终推动 转化科学。 K12项目将为学者提供持续的受保护的时间来提高他们的CT水平 研究由主要导师和共同导师监督，现在由专门的导师进一步加强 委员会，包括一名单独的职业导师，为更广泛的职业目标提供外部意见。培训将 包括使用新课程和计划，包括我们每月的 Translate Together 课程，涵盖 广泛的转化范围，专注于开发改善人类健康的创新解决方案。它 还将包括制定个性化的职业发展计划、领导力培训、知名度 通过参加国家 CTSA 访问学者计划以及导师/受训者培训，以确保 每位学者作为 NCATS 所设想的转化科学家的成功。 K12 还将致力于教育 学者们讨论了社区参与对于执行有效的 CT 研究以确保 可以完成最高质量的科学。在相关背景下，在我们早期成功改善 KL2 计划的多样性，我们将继续开展多项多元化和包容性举措，以确保我们 拥有一支充满活力和多元化的学者群体，同时确保所有学者都受到充分的多元化教育 作为所有成功的 CT 研究工作的一个关键特征。